Cargando...

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk

Results from the Women's Health Initiative (WHI) trial support findings from observational studies that oestrogen–progestin therapy (EPT) use is associated with an increase in breast cancer risk. We conducted a meta-analysis using EPT-specific results from the Collaborative Group on Hormonal Fa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lee, S A, Ross, R K, Pike, M C
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2005
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361783/
https://ncbi.nlm.nih.gov/pubmed/15900297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602617
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!